Why BioNTech Stock Popped Today
Shares of BioNTech (NASDAQ: BNTX) were jumping 8.6% as of 3:13 p.m. EDT on Friday. The nice pop came after the biotech and its partner Pfizer (NYSE: PFE) announced that they have initiated a rolling submission of a regulatory application with the Food and Drug Administration for approval of their COVID-19 vaccine.
The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to win Emergency Use Authorization (EUA) from the FDA in December 2020. The two partners are also the first to file for full FDA approval for a COVID-19 vaccine.
Image source: Getty Images.
Source Fool.com


_0.png?locale=us)